Neurologic attack and dynamic perfusion abnormality in neuronal intranuclear inclusion disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 10, 2017
- Accepted June 26, 2017
- First Published August 23, 2017.
Article Versions
- Previous version (August 23, 2017 - 13:03).
- You are viewing the most recent version of this article.
Author Disclosures
- Koji Fujita, MD*,
- Yusuke Osaki, MD*,
- Ryosuke Miyamoto, MD,
- Yoshimitsu Shimatani, MD,
- Takashi Abe, MD,
- Hiroyuki Sumikura, MD,
- Shigeo Murayama, MD,
- Yuishin Izumi, MD and
- Ryuji Kaji, MD
- Koji Fujita, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yusuke Osaki, MD*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryosuke Miyamoto, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yoshimitsu Shimatani, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Takashi Abe, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hiroyuki Sumikura, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Shigeo Murayama, MD,
NONE
NONE
NONE
Neuropathology, editorial board, since 2004
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The Japanese Governmental Beurearu of Helath, Labor and Welfare, Grants in aid for intractable neurological disorders,2017- 2018, coPI, structured 002, general 0-15, 058, 002, 0-15 & for mental disorders, general 004; Grants in aid provided by National Center for Geriatrics and Gerontology, 2017- 2020, PI 23-42, Co- PI 23-37; Grants in Aid provided by National Center of Neurology and Psychiatry, 2017-2018, Co PI 25-7 The Japanese Governmental Bureau of Education, Technology and Sports, New Aera, Co PI 221S003.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yuishin Izumi, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryuji Kaji, MD
NONE
NONE
NONE
Frontiers in Neurology, Section Editor Neurology and Clinical Neuroscience, Associate Editor
WO2008050866A1 (1) New Generation Botulinum Toxin Preparation (A2NTX)
NONE
NONE
NONE
(1) Glaxo-Smith Kline, Japan, Co Ltd, commercial
NONE
NONE
NONE
Japanese Ministry of Health, Welafare, and Labor (No. 26310301) Japanese Ministry of Education, Culture and Science (No. 24390223)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Institute of Biomedical Sciences (KF, YO, RM, YS, TA, YI, RK), Tokushima University Graduate School, Tokushima; and Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology (HS, SM), Tokyo, Japan.
- Correspondence to:
kof198{at}gmail.com
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Clinical/Scientific Notes
Case of Neuronal Intranuclear Inclusion Disease With Dynamic Perfusion Changes Lacking Typical Signs on Diffusion-Weighted ImagingMai Kikumoto, Tomohisa Nezu, Yuji Shiga et al.Neurology: Genetics, June 09, 2021 -
Articles
Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion diseaseJ. Sone, F. Tanaka, H. Koike et al.Neurology, March 16, 2011 -
Editorials
Neuronal intranuclear inclusion diseaseNo longer a pain in the buttKeith A. Josephs et al.Neurology, March 16, 2011 -
Clinical/Scientific Notes
Neuronal intranuclear inclusion disease showing intranuclear inclusions in renal biopsy 12 years earlierMikiko Motoki, Hideto Nakajima, Tomoe Sato et al.Neurology, October 03, 2018